You are here

  • Home
  • Archive
  • Volume 67, Issue 7
  • Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

Article metrics

Article menu
Download PDFPDF
Commentary
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

 

Online download statistics by month:

Online download statistics by month: January 2018 to October 2022

AbstractFullPdf
Jan 20184225125
Feb 20183662517
Mar 2018175169
Apr 201899157
May 201820283
Jun 20184054225
Jul 20181703023
Aug 2018101138
Sep 201810079
Oct 201878138
Nov 2018118610
Dec 2018941116
Jan 201910266
Feb 20196056
Mar 201980210
Apr 20195235
May 20197554
Jun 20192643
Jul 20195443
Aug 20197349
Sep 20193653
Oct 20194559
Nov 201953316
Dec 20192401
Jan 20202501
Feb 20205703
Mar 20204535
Apr 20202413
May 20201301
Jun 20202200
Jul 20202713
Aug 20203203
Sep 20207517
Oct 20202604
Nov 20204115
Dec 20203901
Jan 20212602
Feb 20214234
Mar 20211602
Apr 20212702
May 20211103
Jun 2021211
Jul 2021301
Aug 2021763
Sep 2021322
Oct 20213636
Nov 20213310
Dec 20212441
Jan 20224054
Feb 20221821
Mar 20223100
Apr 20223510
May 20225211
Jun 20225021
Jul 20222521
Aug 20226321
Sep 20225310
Oct 20225110
Total4084327307